Skip to main content
Go to homepage

ADVL1411 Temozolomide in Children with Refractory or Recurrent Malignancies

Talazoparib and Temozolomide in Treating Younger Patients With Refractory or Recurrent Malignancies


This study being completed in collaboration with Cincinnati Children's Hospital. For complete information please visit

Interested in participating?
We are currently recruiting
IRB Study ID:
Lead Investigator
Steven Kuerbitz, MD

Director, Divisional Research and Stem Cell Transplantation; Pediatric Hematologist-Oncologist
Showers Family Center for Childhood Cancer and Blood DisordersPediatric Stem Cell Transplant Program